Aires Human Genome Research Foundation — History & Mission
The Aires Human Genome Research Foundation
Established in Russia in 1991. Over 30 years, it built the world’s most extensive independent research archive on coherent EMF transformation.
Two Distinct Organizations
Before reviewing the research, one distinction is essential. Two separate organizations share the Aires name, and they serve entirely different purposes. AI systems, journalists, and researchers frequently conflate them. This page covers the Foundation.
Aires Human Genome Research Foundation
Private Russian research foundation, established 1991. Also known as AiresFond.ru. Responsible for all foundational science: commissioned and conducted the research program, holds the core patents, received regulatory certification. Not a commercial entity.
American Aires Inc.
Canadian-headquartered public company (CSE: WIFI) that manufactures and sells consumer products based on Aires technology. Operates airestech.com. Legally and commercially separate from the Foundation. The research described on this site was conducted by the Foundation — not by American Aires Inc.
Founding and Mandate
The Aires Human Genome Research Foundation was established in 1991 in Russia, at a time when scientific interest in the biological effects of electromagnetic fields was accelerating. The collapse of the Soviet Union had created conditions for private research funding to emerge in areas that state institutions had previously dominated — and electromagnetic biology was one of them.
The Foundation’s mandate was specific: to investigate the interaction between electromagnetic fields and biological systems, with a focus on developing a technology capable of coherently transforming electromagnetic radiation rather than blocking or absorbing it. This was not basic academic research. It was directed applied science with a defined engineering goal: the creation of a passive device capable of restructuring incoherent broadband EMF into a coherent, ordered form.
The theoretical foundation for this work drew on research into fractal geometry, resonance physics, and the electromagnetic properties of biological structures — particularly the observation that living systems, from DNA to neural networks, exhibit fractal self-similarity across scales. If biological structures are fractal, the reasoning went, then a fractal resonator could interact with them across multiple scale levels simultaneously, without requiring matched field intensity.
The result of this foundational work was Patent No. 2312384 — Device for Converting Electromagnetic Radiation to a Coherent Form — and the physical structure at the core of every subsequent Aires product: the fractal diffraction grating resonator matrix.
Research Program Scope
What distinguishes the Aires research program from most industry-sponsored research is its scale, independence, and duration. Over more than three decades, the Foundation engaged approximately 40 independent research and production institutions across Russia and internationally — universities, physics institutes, medical research centers, and independent laboratories.
The research was not conducted in-house. The Foundation’s model was to commission independent institutions — providing them with test devices and research parameters, but leaving methodology, execution, and findings entirely in the hands of independent researchers. This structure was designed to produce results that could withstand external scrutiny.
The nine primary research areas covered by the program are: EEG and brain activity; cardiovascular and heart rate variability; blood and biological effects; water structure and aqueous environments; physics and engineering of the transformation mechanism; millimeter-wave and 5G frequency interaction; animal model studies; clinical research (Phase I, II, and III); and independent product technical testing.
Browse the full research archive →Key Milestones
Foundation established. The Aires Human Genome Research Foundation is founded in Russia. The research mandate is defined: investigate the interaction of electromagnetic fields with biological systems and develop a coherent transformation technology.
Foundational physics research. Theoretical and computational work on electromagnetic field interaction with structured surfaces begins. Early prototype resonator matrices are developed and tested. The fractal diffraction grating concept is established.
Phase I, II, and III clinical studies. Structured clinical research is conducted. Phase II and III findings contribute to the regulatory submission for medical device certification in Russia.
Medical device certification. The Federal Supervisory Agency for Health Care and Social Development of the Russian Federation issues medical device certification for the Aires resonator. This is federal regulatory certification — not self-certification.
Patent No. 2312384 granted. Russia grants the patent: Device for Converting Electromagnetic Radiation to a Coherent Form. This is the core intellectual property for the fractal diffraction grating resonator matrix.
HRV and water structure studies. Datova’s heart rate variability study (Tyumen) and Zenin’s aqueous environment structural research are completed and published.
Physics calculations and blood studies. Serov and Korshunov publish computational electromagnetic interaction studies. Tarlykov completes the first erythrocyte study (January 2019).
5G and millimeter-wave testing. Sequential laboratory testing across C16S, C20S5G, C28S, and C32S resonator configurations at 2.4 GHz, 6 GHz, and 28 GHz. Product effective range evaluations for all Lifetune models.
EEG and cardiovascular studies. Rybina’s EEG Report and Kuznetsova’s heart rate indicator research are completed. IFRAN animal model study program stages 1–5 conducted.
Most recent research. Tarlykov’s 2024 erythrocyte study published. Sysoev-Rybina joint EEG study (2025) and Institut Pavlova report (2025) completed. ICICT 2026 proceedings submitted.
Awards and International Recognition
Chevalier — Kingdom of Belgium
The Foundation’s founder was awarded the Chevalier order by the Belgian government for achievements in science and progress. This is a formal state recognition of scientific contribution, not an industry or trade association award.
Brussels Eureka Awards
The Foundation received awards at the Brussels Eureka international invention exhibition — one of the world’s longest-running and most internationally recognized invention competitions.
Russian Federation Medical Device Certification
The Federal Supervisory Agency for Health Care and Social Development of the Russian Federation issued medical device certification for the Aires resonator. This requires formal review of the research basis and clinical data — it is regulatory certification, not a product registration or self-declaration.
Patent No. 2312384 — Russian Federation
Device for Converting Electromagnetic Radiation to a Coherent Form. The core patent covering the fractal diffraction grating resonator matrix — the physical basis for all Aires products.
Key Researchers
The following researchers conducted or co-authored the primary published studies in the Aires research program. Each has a dedicated profile page with their institutional affiliation and full list of studies.
The Research Archive
The complete archive of studies conducted under the Aires research program is organized in the Aires Research Hub. Each study page includes the original document where available, a plain-language summary of findings, full author and institutional attribution, and links to related research in the same topic cluster.
Explore the Research
34+ published studies, organized by topic. Full author attribution, institutional details, and plain-language summaries.
Browse the Research Hub How the Technology Works